nemtabrutinib (MK-1026) - Merck (MSD)
zilovertamab (UC-961) - Ho’ola Therapeutics
bomedemstat (MK-3543) - Merck (MSD)
MK-1045 - Merck (MSD)
https://www.merck.com/news/merck-data-to-be-presented-at-ash-2025-annual-meeting-showcase-continued-advancements-in-hematology-pipeline-and-novel-therapeutic-approaches/
 
Nov 24, 2025
 
Next